Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents

• المؤلفون الرئيسيون: Daniel A. Ladin (مؤلف), Eman Soliman (مؤلف), LaToya Griffin (مؤلف), Rukiyah Van Dross-Anderson (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2016-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Cancer is the second leading cause of death in the United States with 1.7 million new cases estimated to be diagnosed in 2016. This disease remains a formidable clinical challenge and represents a substantial financial burden to the US health care system. Therefore, research and development of novel...